The health food and pet health brand Denza (7889)’s listing on the OTC market has been reviewed and approved and is expected to be listed in the fourth quarter.

The health food and pet health product brand Denshi (7889) has been reviewed and approved by the Overseas Purchase Center. According to the timetable, it is expected to be listed on the counter in the fourth quarter of this year at the earliest.

Denza is mainly engaged in the development, sales and brand management of health foods for general consumers and pets. Thanks to its diversified brand layout and the dual-engine strategy of "human health care" and "pet health", the earnings per share will reach 5.65 yuan in 2025 and 2.24 yuan in the first half of 2026. The cumulative consolidated revenue in the first eight months of this year reached 602 million yuan, an increase of 10.61% over the same period last year.

Denza has been operating in Taiwan's health food market for many years and has successfully built a fleet of health product brands with a multi-brand matrix strategy. Deeply cultivate the online D2C official website and major mainstream e-commerce platforms, including Momo, Shopee, etc., as well as multiple retail channels, and combine AI data analysis and precise digital marketing to drive sales growth across the entire channel.

At the same time, it broke through the traditional health care product price war and promotional red ocean. Through accurate consumer demand, real-time data tracking and sensitive new product research and development, the number of returning shopping members tripled in three years, with a repurchase rate of 65%. The average annual consumption of members of the brand's official website increased by approximately 12.7% during the same period, demonstrating a high degree of customer repurchase power and brand stickiness.

Optimistic about the blue ocean of the pet economy and the huge health demand, the professional pet health care brand "Era" uses patented natural raw materials and certified formulas by a team of professional veterinarians and nutritionists. It has quickly become a leading brand in the pet health care market, and regularly ranks among the pet health care product sales rankings on major e-commerce platforms.

Denza has also joined forces with domestic pet channel leader Wanda Pet (6968) to establish a joint venture subsidiary "Tengda Pet" to comprehensively expand the agency's "ADVANCE" and other brands to hundreds of physical stores and online platforms across Taiwan, providing pet owners with a one-stop high-quality pet health care experience.

Looking forward to the future, Denza will continue to deepen the influence of its four core brands such as "Dharma Materia Medica" and "Maoyidai", combine AI precision technology and big data to understand consumer needs, and accelerate product iteration and new market expansion.